You're reading the free version. Trader adds the live tape and alerts.
Start tracking
IDXG Award Disclosure
Sullivan Stephen J · SEC Form 4 · Filed Aug 20, 2026
Award
Calculated transaction value
$0
Sullivan Stephen J Director
IDXG
Transaction date
Aug 20, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed same day
IDXG daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 69,252 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-039496
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Interpace Biosciences, Inc. IDXG Current | Award | Aug 20, 2026 | $0 |